Search details
1.
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
N Engl J Med
; 385(5): 395-405, 2021 07 29.
Article
in English
| MEDLINE | ID: mdl-34320285
2.
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Breast Cancer Res Treat
; 205(2): 227-239, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38273214
3.
Correction: Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Breast Cancer Res Treat
; 2024 May 05.
Article
in English
| MEDLINE | ID: mdl-38704775
4.
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12.
Eur J Cancer
; 180: 108-116, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36592505
5.
Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT).
Breast Care (Basel)
; 17(1): 1-9, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-35355702
6.
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Breast Care (Basel)
; 17(2): 137-145, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35707180
7.
Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response.
Clin Cancer Res
; 28(4): 697-707, 2022 02 15.
Article
in English
| MEDLINE | ID: mdl-34862246
8.
Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer.
NEJM Evid
; 1(12): EVIDoa2200162, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-38319865
9.
Comparison of high tone therapy and transcutaneous electrical nerve stimulation therapy in chemotherapy-induced polyneuropathy.
Medicine (Baltimore)
; 99(19): e20149, 2020 May.
Article
in English
| MEDLINE | ID: mdl-32384502
10.
Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer.
BMC Cancer
; 9: 367, 2009 Oct 17.
Article
in English
| MEDLINE | ID: mdl-19835621
11.
Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer.
Cancer Chemother Pharmacol
; 62(5): 903-10, 2008 Oct.
Article
in English
| MEDLINE | ID: mdl-18256835
12.
Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes.
Nat Commun
; 9(1): 1219, 2018 03 23.
Article
in English
| MEDLINE | ID: mdl-29572535
13.
Bone-targeted therapy in metastatic breast cancer - all well-established knowledge?
Breast Care (Basel)
; 9(5): 323-30, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-25759612
14.
Neoadjuvant chemotherapy and targeted therapy in breast cancer: past, present, and future.
J Oncol
; 2013: 732047, 2013.
Article
in English
| MEDLINE | ID: mdl-24027583
15.
Capecitabine and Vinorelbine as an All-Oral Chemotherapy in HER2-Negative Locally Advanced and Metastatic Breast Cancer.
Breast Care (Basel)
; 5(3): 158-162, 2010.
Article
in English
| MEDLINE | ID: mdl-21048830
Results
1 -
15
de 15
1
Next >
>>